Search
for
Sort by
Research 91–120 of 1000+
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- PCOS: update and diagnostic approach
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization
- Effect of finasteride on ovulation induction in nonresponder (hyperandrogenic) polycystic ovary syndrome (PCOS) women
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- Estimation of renin and D-dimer levels in women with polycystic ovary disease with or without coronavirus infection
- Disorders of ovulation
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- A Review and a Brief Explanation of the Poly Cystic Ovarian Syndrome
- Greater conversion of testosterone to 5α-dihydrotestosterone, reflecting increased peripheral 5α-reductase activity in nude mice treated with high doses of cyclosporine A
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Polycystic ovary syndrome (PCOS)
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Safety of testosterone treatment in postmenopausal women
- Safety of dermatologic medications in pregnancy and lactation
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
- Menstrual Irregularity in Women with Acromegaly
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Role of insulin resistance and diet in acne
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- A primer for studying cell cycle dynamics of the human hair follicle
- Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome
- Pharmacotherapy of polycystic ovary syndrome - an update
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity